Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflammatory mediators in nasal discharge of chronic rhinosinusitis patients treated with erythromycin
DRKS00000086Phase 3Terminated
- Sponsor
- Johannes Gutenberg University Mainz
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of erythromycin in rhinosinusitis, chronic rhinosinusitis (CRS), sponsored by Johannes Gutenberg University Mainz. Started Feb 2009; status: terminated.
02
Drugs
erythromycin
03
Conditions
rhinosinusitischronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on DRKS00000086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000086.